HIGHLIGHTS
- who: C. Veith et al. from the Department of Pharmacology and Toxicology, NUTRIM School of Nutrition, Translational Research and Metabolism, Faculty Health, Medicine and Life Sciences, University of Maastricht, POBox, MD Maastricht, The Netherlands have published the research: Differences in Treatment Response in Bronchial Epithelial Cells from Idiopathic Pulmonary Fibrosis (IPF) Patients: A First Step towards Personalized Medicine?, in the Journal: Antioxidants 2023, 443 of 11/Nov/2022
- how: Next the authors examined the effect of the selected concentrations of pirfenidone nintedanib and saracatinib onTo mRNA andIPF selected antioxidant Allfor drugs assessexpression the effectsofofNOX4 putative . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.